Literature DB >> 12080184

The alpha 2-adrenergic receptor gene and body fat content and distribution: the HERITAGE Family Study.

Christophe Garenc1, Louis Pérusse, Yvon C Chagnon, Tuomo Rankinen, Jacques Gagnon, Ingrid B Borecki, Arthur S Leon, James S Skinner, Jack H Wilmore, D C Rao, Claude Bouchard.   

Abstract

BACKGROUND: Among adrenergic receptor subtypes that regulate lipid mobilization, the alpha2-adrenergic receptor is involved in the inhibition of fatty acid mobilization from adipose tissue. A C-1291G polymorphism is located in the alpha2-adrenergic receptor gene (ADRA2A) but no association with body fat accumulation has been reported yet.
MATERIALS AND METHODS: Body mass index (BMI), fat mass (FAT), percentage body fat (%FAT), trunk-to-extremity skinfold ratio (TER), sum of eight skinfolds (SF8), and abdominal subcutaneous (ASF), visceral (AVF), and total (ATF) fat areas assessed by CT scan have been measured in adult sedentary white (n = 503) and black (n = 276) subjects participating in the HERITAGE Family Study. Association between the C-1291G polymorphism and each phenotype was tested separately in men and women of each race using ANCOVA with the effects of age as covariate in addition to the effects of BMI for TER and of FAT for AVF, ASF, and ATF.
RESULTS: The allele frequencies of the ADRA2A C-1291G polymorphism differed between races. No association was observed in white subjects, except for a moderate effect of the polymorphism accounting for less than 1% of the variance in AVF and ATF in women. In black subjects, however, the G-1291 allele was found to be associated with an increase of TER in men (3.8% of variance accounted for by the polymorphism), while in black women it was associated with a decrease in TER (2.9%) and in AVF (2.5%).
CONCLUSION: These results suggest a role for the ADRA2A gene in determining the propensity to store fat in the abdominal area, independently of total body fatness.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12080184      PMCID: PMC2039973     

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  16 in total

1.  Alpha-adrenoceptor gene variants and autonomic nervous system function in a young healthy Japanese population.

Authors:  Tetsuro Matsunaga; Koichiro Yasuda; Tetsuya Adachi; Ning Gu; Tsubasa Yamamura; Toshio Moritani; Gozoh Tsujimoto; Kinsuke Tsuda
Journal:  J Hum Genet       Date:  2006-10-31       Impact factor: 3.172

2.  Polymorphism of the adrenergic receptor alpha 2a -1291C>G genetic variation and clozapine-induced weight gain.

Authors:  Y-C Wang; Y-M Bai; J-Y Chen; C-C Lin; I-C Lai; Y-J Liou
Journal:  J Neural Transm (Vienna)       Date:  2005-03-30       Impact factor: 3.575

3.  Complex haplotypes derived from noncoding polymorphisms of the intronless alpha2A-adrenergic gene diversify receptor expression.

Authors:  Kersten M Small; Kari M Brown; Carrie A Seman; Cheryl T Theiss; Stephen B Liggett
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

4.  Alpha-adrenergic receptor gene polymorphisms and cardiovascular reactivity to stress in Black adolescents and young adults.

Authors:  Robert M Kelsey; Bruce S Alpert; Mary K Dahmer; Julia Krushkal; Michael W Quasney
Journal:  Psychophysiology       Date:  2011-11-14       Impact factor: 4.016

5.  Targeting 160 candidate genes for blood pressure regulation with a genome-wide genotyping array.

Authors:  Siim Sõber; Elin Org; Katrin Kepp; Peeter Juhanson; Susana Eyheramendy; Christian Gieger; Peter Lichtner; Norman Klopp; Gudrun Veldre; Margus Viigimaa; Angela Döring; Margus Putku; Piret Kelgo; Sue Shaw-Hawkins; Philip Howard; Abiodun Onipinla; Richard J Dobson; Stephen J Newhouse; Morris Brown; Anna Dominiczak; John Connell; Nilesh Samani; Martin Farrall; Mark J Caulfield; Patricia B Munroe; Thomas Illig; H-Erich Wichmann; Thomas Meitinger; Maris Laan
Journal:  PLoS One       Date:  2009-06-29       Impact factor: 3.240

6.  Alpha2A adrenergic receptor genetic variation contributes to hyperglycemia after myocardial infarction.

Authors:  Abiodun Adefurin; Leon Darghosian; Chimalum Okafor; Vivian Kawai; Chun Li; Anushi Shah; Wei-Qi Wei; Daniel Kurnik; C Michael Stein
Journal:  Int J Cardiol       Date:  2016-04-13       Impact factor: 4.164

7.  Tobacco smoking and the ADRA2A C-1291G polymorphism.

Authors:  A P Prestes; F Z C Marques; M H Hutz; T Roman; C H D Bau
Journal:  J Neural Transm (Vienna)       Date:  2007-07-06       Impact factor: 3.575

8.  ADRA2A Germline Gene Polymorphism is Associated to the Severity, but not to the Risk, of Breast Cancer.

Authors:  Batoul Kaabi; Ghania Belaaloui; Wassila Benbrahim; Kamel Hamizi; Mourad Sadelaoud; Wided Toumi; Hocine Bounecer
Journal:  Pathol Oncol Res       Date:  2015-11-13       Impact factor: 3.201

9.  A controlled pharmacogenetic trial of sibutramine on weight loss and body composition in obese or overweight adults.

Authors:  April B M Grudell; Seth Sweetser; Michael Camilleri; Deborah J Eckert; Maria I Vazquez-Roque; Paula J Carlson; Duane D Burton; Autumn E Braddock; Matthew M Clark; Karen M Graszer; Sarah A Kalsy; Alan R Zinsmeister
Journal:  Gastroenterology       Date:  2008-07-16       Impact factor: 22.682

10.  Using linkage analysis to identify quantitative trait loci for sleep apnea in relationship to body mass index.

Authors:  E K Larkin; S R Patel; R C Elston; C Gray-McGuire; X Zhu; S Redline
Journal:  Ann Hum Genet       Date:  2008-08-26       Impact factor: 1.670

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.